Literature DB >> 24699792

[Diabetes mellitus--risk factor for atrial fibrillation. Potential therapeutic implications].

T Meinertz1, K Sydow.   

Abstract

The relationship between atrial fibrillation and diabetes mellitus type 2 is controversial, and various studies have demonstrated conflicting results. However, the majority of larger prospective studies published during recent years demonstrated a positive correlation. After multivariate adjustment diabetes increased the risk for atrial fibrillation at least two fold. This combination is associated with substantially increased risks of death and cardiovascular events (stroke and heart failure). Atrial fibrillation in patients with diabetes mellitus type 2 identifies individuals who are likely to obtain greater benefits from glycemic control and anticoagulants as well as antihypertensive therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24699792     DOI: 10.1007/s00059-014-4085-2

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  15 in total

1.  The "missing" link in atrial fibrillation heritability.

Authors:  Babar Parvez; Dawood Darbar
Journal:  J Electrocardiol       Date:  2011-09-15       Impact factor: 1.438

2.  Diabetes mellitus, glycemic control, and risk of atrial fibrillation.

Authors:  Sascha Dublin; Nicole L Glazer; Nicholas L Smith; Bruce M Psaty; Thomas Lumley; Kerri L Wiggins; Richard L Page; Susan R Heckbert
Journal:  J Gen Intern Med       Date:  2010-04-20       Impact factor: 5.128

3.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

Authors:  C D Furberg; B M Psaty; T A Manolio; J M Gardin; V E Smith; P M Rautaharju
Journal:  Am J Cardiol       Date:  1994-08-01       Impact factor: 2.778

4.  Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study.

Authors:  Hiroshi Watanabe; Naohito Tanabe; Toru Watanabe; Dawood Darbar; Dan M Roden; Shigeru Sasaki; Yoshifusa Aizawa
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

5.  Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study).

Authors:  Jens Friberg; Henrik Scharling; Niels Gadsbøll; Gorm B Jensen
Journal:  Am J Cardiol       Date:  2003-12-15       Impact factor: 2.778

6.  Atrial fibrillation and obesity--results of a meta-analysis.

Authors:  Nikolas Wanahita; Franz H Messerli; Sripal Bangalore; Apoor S Gami; Virend K Somers; Jonathan S Steinberg
Journal:  Am Heart J       Date:  2007-12-19       Impact factor: 4.749

7.  Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.

Authors:  C J Ostgren; J Merlo; L Råstam; U Lindblad
Journal:  Diabetes Obes Metab       Date:  2004-09       Impact factor: 6.577

8.  Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years.

Authors:  Teresa S M Tsang; Marion E Barnes; Yoko Miyasaka; Stephen S Cha; Kent R Bailey; Grace C Verzosa; James B Seward; Bernard J Gersh
Journal:  Eur Heart J       Date:  2008-07-08       Impact factor: 29.983

9.  Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial).

Authors:  Tonje Amb Aksnes; Roland E Schmieder; Sverre Erik Kjeldsen; Sajda Ghani; Tsushung Augie Hua; Stevo Julius
Journal:  Am J Cardiol       Date:  2008-01-15       Impact factor: 2.778

10.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Authors:  E J Benjamin; D Levy; S M Vaziri; R B D'Agostino; A J Belanger; P A Wolf
Journal:  JAMA       Date:  1994-03-16       Impact factor: 56.272

View more
  1 in total

1.  The Pattern of mRNA Expression Is Changed in Sinoatrial Node from Goto-Kakizaki Type 2 Diabetic Rat Heart.

Authors:  F C Howarth; M A Qureshi; P Jayaprakash; K Parekh; M Oz; H Dobrzynski; T E Adrian
Journal:  J Diabetes Res       Date:  2018-09-02       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.